Clinical Study

A Randomized Trial of Comparing the Efficacy of Two Neurofeedback Protocols for Treatment of Clinical and Cognitive Symptoms of ADHD: Theta Suppression/Beta Enhancement and Theta Suppression/Alpha Enhancement

Table 2

Descriptive statistics on cortical activity in two groups.

Scale GroupBrain areaPretestPosttestFollow-up

DeltaAlphaFrontal0.82 ± 0.570.26 ± 0.200.29 ± 0.25
Central0.64 ± 0.380.40 ± 0.270.45 ± 0.31
BetaFrontal0.55 ± 0.300.33 ± 0.300.31 ± 0.26
Central0.80 ± 0.480.50 ± 0.350.45 ± 0.31

ThetaAlphaFrontal0.70 ± 0.490.48 ± 0.390.45 ± 0.44
Central0.86 ± 0.580.62 ± 0.450.65 ± 0.49
BetaFrontal0.55 ± 0.450.36 ± 0.260.38 ± 0.38
Central0.52 ± 0.360.42 ± 0.290.46 ± 0.32

Alpha 1AlphaFrontal0.58 ± 0.290.53 ± 0.380.53 ± 0.40
Central0.79 ± 0.540.61 ± 0.480.64 ± 0.40
BetaFrontal0.52 ± 0.360.53 ± 0.450.57 ± 0.44
Central0.51 ± 0.410.45 ± 0.300.47 ± 0.494

Alpha 2AlphaFrontal0.55 ± 0.381.12 ± 0.300.89 ± 0.44
Central0.72 ± 0.400.80 ± 0.410.77 ± 0.47
BetaFrontal0.30 ± 0.350.46 ± 0.390.42 ± 0.37
Central0.60 ± 0.570.63 ± 0.510.67 ± 0.49

Beta 1AlphaFrontal0.77 ± 0.550.88 ± 0.570.86 ± 0.49
Central0.82 ± 0.601.26 ± 0.460.878 ± 0.75
BetaFrontal0.43 ± 0.310.73 ± 0.700.69 ± 0.64
Central0.58 ± 0.561.22 ± 0.670.84 ± 0.44